Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nina-Sophie Schmidt-Hegemann"'
Autor:
Luc M. Berclaz, Annelore Altendorf-Hofmann, Lars H. Lindner, Anton Burkhard-Meier, Dorit Di Gioia, Hans Roland Dürr, Alexander Klein, Markus Albertsmeier, Nina-Sophie Schmidt-Hegemann, Frederick Klauschen, Thomas Knösel
Publikováno v:
Cancers, Vol 15, Iss 10, p 2735 (2023)
(1) Background: The expression of T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), an immune checkpoint receptor on T cells, has been associated with dismal outcomes and advanced tumor stages in various solid tumors. The blockade
Externí odkaz:
https://doaj.org/article/902db046cb5647568baff4d5da6aa36f
Autor:
Luc M. Berclaz, Annelore Altendorf-Hofmann, Hans Roland Dürr, Alexander Klein, Martin K. Angele, Markus Albertsmeier, Nina-Sophie Schmidt-Hegemann, Dorit Di Gioia, Thomas Knösel, Lars H. Lindner
Publikováno v:
Cancers, Vol 13, Iss 19, p 4877 (2021)
Molecular predictors of response to chemotherapy and survival have not been put into clinical practice in high-risk soft tissue sarcomas (HR-STS) by now. The expression of TOP2A and SIRT1 has implications for the mechanism of action of doxorubicin, w
Externí odkaz:
https://doaj.org/article/42b362908f064b6ba4a7de9842493d97
Autor:
Run Shi, Xuanwen Bao, Paul Rogowski, Christian Schäfer, Nina-Sophie Schmidt-Hegemann, Kristian Unger, Shun Lu, Jing Sun, Alexander Buchner, Christian Stief, Claus Belka, Minglun Li
Publikováno v:
Cancers, Vol 12, Iss 5, p 1146 (2020)
More accurate models are essential to identify high-risk bladder cancer (BCa) patients who will benefit from adjuvant therapies and thus helpful to facilitate personalized management of BCa. Among various cancer-related hallmarks and pathways, cell c
Externí odkaz:
https://doaj.org/article/9bd51a37b84d4726836dff52a78d1866
Autor:
Nina-Sophie Schmidt-Hegemann, Minglun Li, Christian G. Stief, Alexander Buchner, Shun Lu, Claus Belka, Run Shi, Xuanwen Bao, Paul Rogowski, Christian Schäfer, Kristian Unger, Jing Sun
Publikováno v:
Cancers, Vol 12, Iss 1146, p 1146 (2020)
Cancers
Cancers 12:1146 (2020)
Volume 12
Issue 5
Cancers
Cancers 12:1146 (2020)
Volume 12
Issue 5
More accurate models are essential to identify high-risk bladder cancer (BCa) patients who will benefit from adjuvant therapies and thus helpful to facilitate personalized management of BCa. Among various cancer-related hallmarks and pathways, cell c
Autor:
Alexander Klein, Nina-Sophie Schmidt-Hegemann, Markus Albertsmeier, Annelore Altendorf-Hofmann, Martin K. Angele, Luc M Berclaz, Lars H. Lindner, Dorit Di Gioia, Hans Roland Dürr, Thomas Knösel
Publikováno v:
Cancers
Volume 13
Issue 19
Cancers, Vol 13, Iss 4877, p 4877 (2021)
Volume 13
Issue 19
Cancers, Vol 13, Iss 4877, p 4877 (2021)
Simple Summary High-risk soft tissue sarcomas (HR-STS) account for less than 1% of all malignancies in adults. Despite optimal local treatment, almost half of patients will die within five years of their diagnosis. Chemoresistance is a major responsi
Autor:
Christian G. Stief, Nina-Sophie Schmidt-Hegemann, Xuanbin Wang, Run Shi, Joachim Weischenfeldt, Xuanwen Bao, Claus Belka, Thorsten Schlomm, Christian Schaefer, Kristian Unger, Alexander Buchner, Minglun Li, Paul Rogowski, Kirsten Lauber
Publikováno v:
Cancers
Volume 12
Issue 1
Cancers 12:1 (2020)
Shi, R, Bao, X, Weischenfeldt, J, Schaefer, C, Rogowski, P, Schmidt-Hegemann, N-S, Unger, K, Lauber, K, Wang, X, Buchner, A, Stief, C, Schlomm, T, Belka, C & Li, M 2020, ' A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy ', Cancers, vol. 12, no. 1, pp. 1-12 . https://doi.org/10.3390/cancers12010001
Volume 12
Issue 1
Cancers 12:1 (2020)
Shi, R, Bao, X, Weischenfeldt, J, Schaefer, C, Rogowski, P, Schmidt-Hegemann, N-S, Unger, K, Lauber, K, Wang, X, Buchner, A, Stief, C, Schlomm, T, Belka, C & Li, M 2020, ' A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy ', Cancers, vol. 12, no. 1, pp. 1-12 . https://doi.org/10.3390/cancers12010001
Currently, decision-making regarding biochemical recurrence (BCR) following prostatectomy relies solely on clinical parameters. We therefore attempted to develop an integrated prediction model based on a molecular signature and clinicopathological fe
Autor:
Nina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, Christian Schäfer, Christian Stief, Sebastian Lang, Simon Spohn, Rieke Steffens, Minglun Li, Christian Gratzke, Wolfgang Schultze-Seemann, Harun Ilhan, Wolfgang Peter Fendler, Peter Bartenstein, Ute Ganswindt, Alexander Buchner, Anca-Ligia Grosu, Claus Belka, Philipp Tobias Meyer, Simon Kirste, Constantinos Zamboglou
Publikováno v:
Cancers, Vol 12, Iss 11, p 3395 (2020)
The purpose of this analysis was primarily to analyze biochemical-recurrence free survival (BRFS) after positron emission tomography (PET)-guided salvage radiotherapy (sRT) in a large cohort, and to further compare BRFS after PSMA vs. choline PET/ co
Externí odkaz:
https://doaj.org/article/5a3443955e414a55ae8be6b39e17f30c